545 related articles for article (PubMed ID: 15231157)
1. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
[TBL] [Abstract][Full Text] [Related]
2. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
3. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
Sun Z; Zhu Y; Stjernsward J; Hilleman M; Collins R; Zhen Y; Hsia CC; Lu J; Huang F; Ni Z
Cancer Detect Prev; 1991; 15(4):313-8. PubMed ID: 1665400
[TBL] [Abstract][Full Text] [Related]
4. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
[TBL] [Abstract][Full Text] [Related]
5. [Study on the afficacy of hepatitis B immunization among youngsters in Beijing].
Gong XH; Li YH; Liu LR; Jia L; Xing YL; Wang YQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):388-90. PubMed ID: 15231158
[TBL] [Abstract][Full Text] [Related]
6. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
Chang MH; You SL; Chen CJ; Liu CJ; Lee CM; Lin SM; Chu HC; Wu TC; Yang SS; Kuo HS; Chen DS;
J Natl Cancer Inst; 2009 Oct; 101(19):1348-55. PubMed ID: 19759364
[TBL] [Abstract][Full Text] [Related]
7. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
9. [Hepatocellular carcinoma: a preventable cancer].
Viviani S; Jack A; Bah E; Montesano R
Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.
Zanetti A
Ital J Gastroenterol; 1992 Feb; 24(2):100-2. PubMed ID: 1315589
[TBL] [Abstract][Full Text] [Related]
11. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.
Chang MH; Chen CJ; Lai MS; Hsu HM; Wu TC; Kong MS; Liang DC; Shau WY; Chen DS
N Engl J Med; 1997 Jun; 336(26):1855-9. PubMed ID: 9197213
[TBL] [Abstract][Full Text] [Related]
12. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems.
Chang MH; Chen TH; Hsu HM; Wu TC; Kong MS; Liang DC; Ni YH; Chen CJ; Chen DS;
Clin Cancer Res; 2005 Nov; 11(21):7953-7. PubMed ID: 16278421
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis B vaccine prevention of the non-newborn populations in Beijing area].
Xing YL; Gong XH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):381-4. PubMed ID: 15231156
[No Abstract] [Full Text] [Related]
15. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
16. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
[TBL] [Abstract][Full Text] [Related]
17. Reduction of hepatocellular carcinoma in childhood after introduction of selective vaccination against hepatitis B virus for infants born to HBV carrier mothers.
Tajiri H; Tanaka H; Brooks S; Takano T
Cancer Causes Control; 2011 Mar; 22(3):523-7. PubMed ID: 21191808
[TBL] [Abstract][Full Text] [Related]
18. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period.
Park NH; Chung YH; Lee HS
Intervirology; 2010; 53(1):20-8. PubMed ID: 20068337
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B immunization and hepatocellular carcinoma: The Gambia Hepatitis Intervention Study.
Montesano R
J Med Virol; 2002 Jul; 67(3):444-6. PubMed ID: 12116042
[TBL] [Abstract][Full Text] [Related]
20. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
